SCHEMBL4934173

SCHEMBL4934173

Nc1n[c]ccc1NCc1cccc(-c2cccnc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 6/20 0.70
▸ EPHX2 P34913 1/20 0.53
▸ PRMT6 Q96LA8 1/20 0.53
▸ KDM4C Q9H3R0 1/20 0.45
▸ MEN1 O00255 3/20 0.43
▸ MKNK1 Q9BUB5 2/20 0.43
▸ MKNK2 Q9HBH9 2/20 0.43
▸ PSIP1 O75475 1/20 0.43
▸ AXL P30530 1/20 0.43
▸ HDAC1 Q13547 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ CYP1A2 P05177 6/20 0.41
▸ CYP3A4 P08684 6/20 0.41
▸ CYP2D6 P10635 6/20 0.41
▸ CYP2C19 P33261 6/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ HSD17B10 Q99714 5/20 0.41
▸ CLK4 Q9HAZ1 4/20 0.41
▸ HPGD P15428 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8264924 0.83 BACE1 (1.00) BACE1EPHX2PRMT6KDM4CMEN1
SCHEMBL29941429 0.83 BACE1 (1.00) BACE1EPHX2PRMT6KDM4CMEN1
SCHEMBL14007508 0.82 BACE1 (0.72) BACE1EPHX2PRMT6KDM4CMEN1
SCHEMBL4931083 0.80 BACE1 (0.69) BACE1EPHX2PRMT6KDM4CMEN1
SCHEMBL8265552 0.76 BACE1 (0.74) BACE1EPHX2PRMT6KDM4CMEN1
SCHEMBL8264450 0.74 BACE1 (0.83) BACE1EPHX2PRMT6KDM4CHDAC1
SCHEMBL1038487 0.70 PRMT6 (1.00) BACE1EPHX2PRMT6MEN1MKNK1
SCHEMBL5215132 0.70 BACE1 (0.78) BACE1PRMT6KDM4CMKNK2CLK4
SCHEMBL14034556 0.69 BACE1 (0.76) BACE1EPHX2PRMT6KDM4C
SCHEMBL8263982 0.69 BACE1 (0.76) BACE1EPHX2PRMT6KDM4CMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287399-A1 Substituted Aminopyridines and Uses Thereof ASTRAZENECA AB (SE) 2008-11-20 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287399-A1 Substituted Aminopyridines and Uses Thereof PSEN2, SLC1A2, PSEN1 BACE1 30/4885EPHX2 3101/4885PRMT6 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback